The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist
Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings. For the treatment of peptide-secreting enteroendocrine cells, most research has focused on developing peptide multi-agonists as most o...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
The Korean Society of Lipid and Atherosclerosis
2023-09-01
|
| Rangatū: | Journal of Lipid and Atherosclerosis |
| Ngā marau: | |
| Urunga tuihono: | https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2023.12.3.213&code=9992JLA&vmode=FULL |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|